Archives exelixis

by in
Entry Author Date Location
Exelixis Passes Key Test With Lead Drug; Stock Soars 10/24/11 San Francisco
What Most Biotechies Are Missing on Twitter: A Huge Networking Opportunity 09/12/11 National
George Scangos, the Boy From Working Class Boston, on His Road Back to Lead Biogen Idec 08/31/11 Boston
Encouraged by Early Work on Anti-Cancer Drug, Intellikine Hires New Head for Clinical Trials 07/18/11 San Diego
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
iPierian Shakeup Continues, as Chairman Corey Goodman, Scientist Doug Melton Exit Stem Cell Startup 06/15/11 San Francisco
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S. 06/07/11 National
Exelixis Zeroes in on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients 06/06/11 San Francisco
The Quest For Biotech Independence: Maybe It Isn’t So Quixotic After All 06/06/11 National
FivePrime Nabs Partner, Solazyme’s $100M IPO Plan, Where Blockbuster Drugs Come From, & More Bay Area Life Sciences News 03/18/11 San Francisco
Exelixis Tacks on $23M 03/15/11 San Francisco
Exelixis Bags $156M, Tethys Bets on Prevention, UCSF’s Delicate Dance With Industry, & More Bay Area Life Sciences News 03/11/11 San Francisco
Exelixis Pockets $156M in Stock Sale, Riding Wave of Prostate Cancer Drug Results 03/09/11 San Francisco
Big Pharma’s Hardball Tactics Won’t Kill Biotech, But They Could Kill Off Some Pharmas 02/28/11 National
Testing Experimental Drugs in Combination – A New Trend 12/22/10 San Diego
Roche Cutting Hundreds of Jobs, Exelixis Shares Soar, Sutro Pockets $36.5M, & More Bay Area Life Sciences News 11/19/10 San Francisco
Exelixis Shares Soar on Cancer Results 11/18/10 San Francisco
Biogen Idec Axes 650 Jobs, Closes San Diego Site, Bets Future on Neurology 11/03/10 Boston
Exelixis Seeks to Exit Doghouse, Sangamo Morphs Into Drugmaker, Siluria Adds $13M, & More Bay Area Life Sciences News 10/22/10 San Francisco
Exelixis Seeks to Climb From the Penalty Box, Prove its Lead Drug Still Has Legs 10/20/10 San Francisco
Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News 10/15/10 San Francisco
Exelixis Nabs $60M Upfront, Potentially $505M More, From New Deal With Bristol-Myers 10/11/10 San Francisco
Plexxikon Shows How New Drug Hits Molecular Target for Deadly Skin Cancer 09/07/10 San Francisco
Onyx Moving to South SF 07/14/10 San Francisco
Infinity Pharma, Intellikine Strike Deal to Make Cancer Drugs Against Hot Target 07/08/10 Boston
PhyloTech, Corey Goodman’s First Environmental Health Startup, Raises $1.2M in Seed Capital 07/06/10 San Francisco
Exelixis CEO Takes Biogen Gig, What Drives Brook Byers Crazy, The Mission Bay Biotech Cluster, & More Bay Area Life Sciences News 07/02/10 San Francisco
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News 07/02/10 Boston
New CEO George Scangos Says Biogen Idec’s R&D Has to Improve 07/01/10 Boston
Exelixis Promotes Morrissey to CEO, Replacing Scangos as He Heads to Biogen Idec 06/30/10 San Francisco
Page 2 of 3 « previous page · next page »